These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 7929212
1. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms. Tzahar E, Levkowitz G, Karunagaran D, Yi L, Peles E, Lavi S, Chang D, Liu N, Yayon A, Wen D. J Biol Chem; 1994 Oct 07; 269(40):25226-33. PubMed ID: 7929212 [Abstract] [Full Text] [Related]
2. An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4. Chen X, Levkowitz G, Tzahar E, Karunagaran D, Lavi S, Ben-Baruch N, Leitner O, Ratzkin BJ, Bacus SS, Yarden Y. J Biol Chem; 1996 Mar 29; 271(13):7620-9. PubMed ID: 8631797 [Abstract] [Full Text] [Related]
3. Targeted inhibition of tumor-cell growth by recombinant heregulin-toxin fusion proteins. Jeschke M, Wels W, Dengler W, Imber R, Stöcklin E, Groner B. Int J Cancer; 1995 Mar 03; 60(5):730-9. PubMed ID: 7860149 [Abstract] [Full Text] [Related]
4. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. Beerli RR, Hynes NE. J Biol Chem; 1996 Mar 15; 271(11):6071-6. PubMed ID: 8626392 [Abstract] [Full Text] [Related]
5. Heregulin activation of extracellular acidification in mammary carcinoma cells is associated with expression of HER2 and HER3. Chan SD, Antoniucci DM, Fok KS, Alajoki ML, Harkins RN, Thompson SA, Wada HG. J Biol Chem; 1995 Sep 22; 270(38):22608-13. PubMed ID: 7673253 [Abstract] [Full Text] [Related]
6. Neu differentiation factor inhibits EGF binding. A model for trans-regulation within the ErbB family of receptor tyrosine kinases. Karunagaran D, Tzahar E, Liu N, Wen D, Yarden Y. J Biol Chem; 1995 Apr 28; 270(17):9982-90. PubMed ID: 7730382 [Abstract] [Full Text] [Related]
7. Structural and functional aspects of the multiplicity of Neu differentiation factors. Wen D, Suggs SV, Karunagaran D, Liu N, Cupples RL, Luo Y, Janssen AM, Ben-Baruch N, Trollinger DB, Jacobsen VL. Mol Cell Biol; 1994 Mar 28; 14(3):1909-19. PubMed ID: 7509448 [Abstract] [Full Text] [Related]
8. ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes. Marikovsky M, Lavi S, Pinkas-Kramarski R, Karunagaran D, Liu N, Wen D, Yarden Y. Oncogene; 1995 Apr 06; 10(7):1403-11. PubMed ID: 7731691 [Abstract] [Full Text] [Related]
9. Binding of Neu differentiation factor with the extracellular domain of Her2 and Her3. Horan T, Wen J, Arakawa T, Liu N, Brankow D, Hu S, Ratzkin B, Philo JS. J Biol Chem; 1995 Oct 13; 270(41):24604-8. PubMed ID: 7592681 [Abstract] [Full Text] [Related]
10. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells. Ram TG, Kokeny KE, Dilts CA, Ethier SP. J Cell Physiol; 1995 Jun 13; 163(3):589-96. PubMed ID: 7775601 [Abstract] [Full Text] [Related]
11. Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Chang H, Riese DJ, Gilbert W, Stern DF, McMahan UJ. Nature; 1997 May 29; 387(6632):509-12. PubMed ID: 9168114 [Abstract] [Full Text] [Related]
12. Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations. Pinkas-Kramarski R, Shelly M, Glathe S, Ratzkin BJ, Yarden Y. J Biol Chem; 1996 Aug 09; 271(32):19029-32. PubMed ID: 8702572 [Abstract] [Full Text] [Related]
13. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells. Marte BM, Jeschke M, Graus-Porta D, Taverna D, Hofer P, Groner B, Yarden Y, Hynes NE. Mol Endocrinol; 1995 Jan 09; 9(1):14-23. PubMed ID: 7760847 [Abstract] [Full Text] [Related]
14. ErbB kinases and NDF signaling in human prostate cancer cells. Grasso AW, Wen D, Miller CM, Rhim JS, Pretlow TG, Kung HJ. Oncogene; 1997 Nov 27; 15(22):2705-16. PubMed ID: 9400997 [Abstract] [Full Text] [Related]
15. Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships. Peles E, Ben-Levy R, Tzahar E, Liu N, Wen D, Yarden Y. EMBO J; 1993 Mar 27; 12(3):961-71. PubMed ID: 8096177 [Abstract] [Full Text] [Related]
16. Bivalence of EGF-like ligands drives the ErbB signaling network. Tzahar E, Pinkas-Kramarski R, Moyer JD, Klapper LN, Alroy I, Levkowitz G, Shelly M, Henis S, Eisenstein M, Ratzkin BJ, Sela M, Andrews GC, Yarden Y. EMBO J; 1997 Aug 15; 16(16):4938-50. PubMed ID: 9305636 [Abstract] [Full Text] [Related]
17. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. Baulida J, Kraus MH, Alimandi M, Di Fiore PP, Carpenter G. J Biol Chem; 1996 Mar 01; 271(9):5251-7. PubMed ID: 8617810 [Abstract] [Full Text] [Related]
18. Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2. Beerli RR, Graus-Porta D, Woods-Cook K, Chen X, Yarden Y, Hynes NE. Mol Cell Biol; 1995 Dec 01; 15(12):6496-505. PubMed ID: 8524214 [Abstract] [Full Text] [Related]
19. Neu and its ligands: from an oncogene to neural factors. Peles E, Yarden Y. Bioessays; 1993 Dec 01; 15(12):815-24. PubMed ID: 7908191 [Abstract] [Full Text] [Related]
20. A Neu differentiation factor (NDF) domain essential for proliferation and alterations in morphology of colonic epithelial cells in vitro. Whoriskey JS, Pekar SK, Elliott GS, Hara S, Liu N, Lenz DM, Zamborelli T, Mayer JP, Tarpley JE, Lacey DL, Ratzkin B, Yoshinaga SK. Growth Factors; 1998 Dec 01; 15(4):307-21. PubMed ID: 9714914 [Abstract] [Full Text] [Related] Page: [Next] [New Search]